An insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome

• 收藏
• 分享

专利权人:

LLC;IGF Oncology

发明人:

McTavish, Hugh,Dudek, Arkadiusz Z.

申请号：

AU2018273370

公开号：

AU2018273370A1

申请日:

2018.05.21

申请国别(地区):

AU

年份:

2019

代理人:

摘要：

Provided are methods of treating myelodysplastic syndrome (MDS), oligoblastic acute myelogenous leukemia (O-AML), or chronic myelomonocytic leukemia (CMML) using 765IGF-MTX and other IGF-receptor-targeted agents, and formulations for delivering 765IGF-MTX and other IGF-receptor-targeted agents to patients. Also provided are pharmaceutical compositions for use in treating MDS, O-AML, and CMML.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/